Cleared Traditional

K133894 - SURFLO WINGED INFUSION SET WITH FILTER & NEEDLE PROTECTION (SURSHIELD)

K133894 is an FDA 510(k) clearance for SURFLO WINGED INFUSION SET WITH FILTER ..., manufactured by Terumo Europe N.V.. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 88-day FDA review.

K133894 · Terumo Europe N.V. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2014
Decision
88d
Days
Class 2
Risk

K133894 is an FDA 510(k) clearance for the SURFLO WINGED INFUSION SET WITH FILTER & NEEDLE PROTECTION (SURSHIELD). Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Terumo Europe N.V. (Leuven, BE). The FDA issued a Cleared decision on March 18, 2014 after a review of 88 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Terumo Europe N.V. devices

FDA 510(k) Submission Details - K133894

510(k) Number K133894 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 20, 2013
Decision Date March 18, 2014
Days to Decision 88 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
41d faster than avg
Panel avg: 129d · This submission: 88d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 768
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K133894.
MAXZERO EXTENSION SET WITH NEEDLESS CONNECTOR
K140831 · Care Fusion · Apr 2014
SUB-Q SUBCUTANEOUS TISSUE INFUSION SET
K140131 · Emed Technologies Corporation · Apr 2014
CAIR DRIVE, NEUTRACLEAR
K133073 · Cair Lgl · Mar 2014
SURFLO WINGED INFUSION SET WITH NEEDLE PROTECTION (SURSHIELD)
K133867 · Terumo Europe N.V. · Feb 2014
ZYNO MEDICAL ADMINISTRATION SET
K132841 · Zyno Medical, LLC · Jan 2014
MEDCOMP POWER INJECTABLE SAFETY HUBER NEEDLE
K132880 · Medical Components, Inc. · Jan 2014